Our results identify a c-Myc-driven IDH3-mediated metabolic switch toward OXPHOS as a critical mechanism supporting the survival of quiescent cancer cells, suggesting that targeting OXPHOS in combination with therapeutic agents that predominantly effect on cycling cells as a potential strategy towards curative treatment of cancer 83. Here, MYC is linked to cancer.